Ignite Creation Date:
2025-12-26 @ 1:16 PM
Ignite Modification Date:
2025-12-30 @ 7:57 AM
Study NCT ID:
NCT00030706
Status:
COMPLETED
Last Update Posted:
2018-09-28
First Post:
2002-02-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer
Sponsor:
Montefiore Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-11
Start Date Type:
ACTUAL
Primary Completion Date:
2007-02
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2002-02-14
First Submit QC Date:
None
Study First Post Date:
2003-01-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-09-27
Last Update Post Date:
2018-09-28
Last Update Post Date Type:
ACTUAL